Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany A Traina

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancerAna M Gonzalez-Angulo, Katherine Stemke-Hale, Shana L Palla, et al.
Breast Cancer Research and Treatment|July 3, 2020
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancerDiana G Wang, Dulce M Barrios, Victoria S Blinder, et al.
Breast Cancer Research and Treatment|February 9, 2018
First international TNBC conference meeting reportPadmashree Rida, Angela Ogden, Ian O Ellis, et al.
JAMA Network Open|November 28, 2019
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical TrialNeil M Iyengar, Lillian M Smyth, Diana Lake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast CancerSiang-Boon Koh, Kenneth Ross, Steven J Isakoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2018
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast CancerTiffany A Traina, Kathy Miller, Denise A Yardley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2014
Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?Jeanne S Mandelblatt, Robert A Stern, Gheorghe Luta, et al.
Breast Cancer Research and Treatment|August 3, 2024
Oral minoxidil for late alopecia in cancer survivorsAlyce Mei-Shiuan Kuo, Rachel E Reingold, Kwami F Ketosugbo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancerTiffany A Traina, Hope S Rugo, James F Caravelli, et al.
Breast Cancer Research and Treatment|August 20, 2022
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility studyElaine M Walsh, Ayca Gucalp, Sujata Patil, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancerAna M Gonzalez-Angulo, Katherine Stemke-Hale, Shana L Palla, et al.
Breast Cancer Research and Treatment|July 3, 2020
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancerDiana G Wang, Dulce M Barrios, Victoria S Blinder, et al.
Breast Cancer Research and Treatment|February 9, 2018
First international TNBC conference meeting reportPadmashree Rida, Angela Ogden, Ian O Ellis, et al.
JAMA Network Open|November 28, 2019
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical TrialNeil M Iyengar, Lillian M Smyth, Diana Lake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast CancerSiang-Boon Koh, Kenneth Ross, Steven J Isakoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2018
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast CancerTiffany A Traina, Kathy Miller, Denise A Yardley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 21, 2014
Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?Jeanne S Mandelblatt, Robert A Stern, Gheorghe Luta, et al.
Breast Cancer Research and Treatment|August 3, 2024
Oral minoxidil for late alopecia in cancer survivorsAlyce Mei-Shiuan Kuo, Rachel E Reingold, Kwami F Ketosugbo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancerTiffany A Traina, Hope S Rugo, James F Caravelli, et al.
Breast Cancer Research and Treatment|August 20, 2022
Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility studyElaine M Walsh, Ayca Gucalp, Sujata Patil, et al.
Pageof 7